title: Sputum processing for evaluation of inflammatory mediators.
abstract: Neutrophil-dominated inflammation is prominent in the cystic fibrosis (CF) and chronic bronchitis (CB) airways. We assessed the degree of airway inflammation by measuring the sputum concentrations of interleukin (IL)-8, myeloperoxidase (MPO), and deoxyribonucleic acid (DNA). We determined the relationship among the concentrations of these mediators and investigated methodological problems that may be responsible for reported variability in measurements. Sputa obtained from 31 patients were solubilized with phosphate-buffered saline, dithiothreitol (DTT) (0.1% or 1%), or dornase alfa (0.2 mg/mL). The sputum concentration of IL-8 and MPO was measured by enzyme-linked immunosorbent assay (ELISA), and DNA was measured using microfluorimetry. There was a significant relationship among sputum IL-8, MPO, and DNA. For MPO (means +/- SD), CF was 1,392 +/- 771 vs. CB at 75 +/- 65 mcg/mL; P < 0.0001. For IL-8: CF was 239 +/- 154 vs. CB at 121 +/- 108 ng/mL; P = 0.0002. For DNA, CF was 1.707 +/- 1.25 vs. CB at 0.184 +/- 0.272 mg/mL; P < 0.0001. The MPO concentration in CF sputum was approximately double after in vitro treatment with dornase alfa (P < 0.0001). There is a greater concentration of IL-8, MPO, and DNA in CF than in CB sputa. There is a significant relationship among these inflammatory markers in sputum. DNA polymers bind myeloperoxidase in the sputum, and we speculate that treatment with dornase alfa may remove a source of MPO inhibition.
authors.affiliation: Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Kim
authors.forename: G H
authors.initials: GH
authors.lastname: Hackley
authors.forename: K
authors.initials: K
authors.lastname: Okamoto
authors.forename: B K
authors.initials: BK
authors.lastname: Rubin
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000032:analysis; D001991:Bronchitis / Q000503:physiopathology*; D002648:Child; D003550:Cystic Fibrosis / Q000503:physiopathology*; D004247:DNA / Q000032:analysis*; D003850:Deoxyribonuclease I / Q000494:pharmacology; D005100:Expectorants / Q000494:pharmacology; D005260:Female; D006801:Humans; D007249:Inflammation; D016209:Interleukin-8 / Q000032:analysis*; D008297:Male; D009195:Peroxidase / Q000032:analysis*; D011108:Polymers; D011994:Recombinant Proteins / Q000494:pharmacology; D013048:Specimen Handling; D013183:Sputum / Q000737:chemistry*
chemical_list: D015415:Biomarkers; D005100:Expectorants; D016209:Interleukin-8; D011108:Polymers; D011994:Recombinant Proteins; D004247:DNA; D009195:Peroxidase; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I